Related Experiment Video
Updated: Feb 2, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Anti-inflammatory Activity of Tocotrienols in Age-related Pathologies: A SASPected Involvement of Cellular Senescence
Marco Malavolta1, Elisa Pierpaoli1, Robertina Giacconi1
1Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, via Birarelli 8, 60121 Ancona, Italy.
Abstract:
Tocotrienols (T3) have been shown to represent a very important part of the vitamin E family since they have opened new opportunities to prevent or treat a multitude of age-related chronic diseases. The beneficial effects of T3 include the amelioration of lipid profile, the promotion of Nrf2 mediated cytoprotective activity and the suppression of inflammation. All these effects may be the consequence of the ability of T3 to target multiple pathways. We here propose that these effects may be the result of a single target of T3, namely senescent cells. Indeed, T3 may act by a direct suppression of the senescence-associated secretory phenotype (SASP) produced by senescent cells, mediated by inhibition of NF-kB and mTOR, or may potentially remove the origin of the SASP trough senolysis (selective death of senescent cells). Further studies addressed to investigate the impact of T3 on cellular senescence "in vitro" as well as in experimental models of age-related diseases "in vivo" are clearly encouraged.
Insights
Tocotrienols (T3), a form of vitamin E, may combat age-related diseases by targeting senescent cells. T3 potentially reduces inflammation and improves health by inhibiting the senescence-associated secretory phenotype (SASP).
Area of Science:
- Biochemistry
- Gerontology
- Cell Biology
Background:
- Tocotrienols (T3) are vital vitamin E compounds with potential therapeutic applications.
- T3 exhibit beneficial effects including improved lipid profiles, enhanced Nrf2-mediated cytoprotection, and reduced inflammation.
- These effects suggest T3 target multiple pathways relevant to age-related diseases.
Purpose of the Study:
- To investigate the potential of tocotrienols (T3) as a therapeutic agent targeting cellular senescence.
- To explore the hypothesis that T3's benefits stem from their interaction with senescent cells.
Main Methods:
- The study proposes investigating T3's impact on the senescence-associated secretory phenotype (SASP).
- Mechanisms explored include inhibition of NF-kB and mTOR pathways.
- Potential senolytic activity of T3 is also considered.
Main Results:
- T3 may directly suppress the SASP by inhibiting NF-kB and mTOR.
- T3 might induce senolysis, selectively eliminating senescent cells.
- These actions could underlie T3's observed health benefits.
Conclusions:
- Tocotrienols (T3) show promise in managing age-related diseases through a novel mechanism targeting cellular senescence.
- Further in vitro and in vivo studies are warranted to validate T3's senolytic and anti-SASP effects.
Related Concept Videos
Inflammatory Response I: Vascular and Cellular
Replicative Cell Senescence
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...

